Literature DB >> 25006393

Prenatal programming of pulmonary hypertension induced by chronic hypoxia or ductal ligation in sheep.

Demosthenes G Papamatheakis1, Madalitso Chundu2, Arlin B Blood3, Sean M Wilson2.   

Abstract

Pulmonary hypertension of the newborn is caused by a spectrum of functional and structural abnormalities of the cardiopulmonary circuit. The existence of multiple etiologies and an incomplete understanding of the mechanisms of disease progression have hindered the development of effective therapies. Animal models offer a means of gaining a better understanding of the fundamental basis of the disease. To that effect, a number of experimental animal models are being used to generate pulmonary hypertension in the fetus and newborn. In this review, we compare the mechanisms associated with pulmonary hypertension caused by two such models: in utero ligation of the ductus arteriosus and chronic perinatal hypoxia in sheep fetuses and newborns. In this manner, we make direct comparisons between ductal ligation and chronic hypoxia with respect to the associated mechanisms of disease, since multiple studies have been performed with both models in a single species. We present evidence that the mechanisms associated with pulmonary hypertension are dependent on the type of stress to which the fetus is subjected. Such an analysis allows for a more thorough evaluation of the disease etiology, which can help focus clinical treatments. The final part of the review provides a clinical appraisal of current treatment strategies and lays the foundation for developing individualized therapies that depend on the causative factors.

Entities:  

Keywords:  chronic hypoxia; ductal ligation; pulmonary hypertension; sheep prenatal programming

Year:  2013        PMID: 25006393      PMCID: PMC4070839          DOI: 10.1086/674767

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  202 in total

1.  Cyclic nucleotide phosphodiesterases: critical modulators of endocrine, metabolic, and cardiovascular function and appealing therapeutic targets.

Authors:  Vincent Manganiello
Journal:  Curr Opin Pharmacol       Date:  2011-11-10       Impact factor: 5.547

2.  Pulmonary vascular effects of nitric oxide-cGMP augmentation in a model of chronic pulmonary hypertension in fetal and neonatal sheep.

Authors:  Philippe Deruelle; Theresa R Grover; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-06-17       Impact factor: 5.464

3.  The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension.

Authors:  C A Elliot; P Stewart; V J Webster; G H Mills; S P Hutchinson; E S Howarth; F A Bu'lock; R A Lawson; I J Armstrong; D G Kiely
Journal:  Eur Respir J       Date:  2005-07       Impact factor: 16.671

4.  Developmental change in isoproterenol-mediated relaxation of pulmonary veins of fetal and newborn lambs.

Authors:  Y Gao; J F Tolsa; M Botello; J U Raj
Journal:  J Appl Physiol (1985)       Date:  1998-05

5.  Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension.

Authors:  Marc Chester; Gregory Seedorf; Pierre Tourneux; Jason Gien; Nancy Tseng; Theresa Grover; Jason Wright; Johannes-Peter Stasch; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-08-19       Impact factor: 5.464

6.  Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group.

Authors:  R H Clark; T J Kueser; M W Walker; W M Southgate; J L Huckaby; J A Perez; B J Roy; M Keszler; J P Kinsella
Journal:  N Engl J Med       Date:  2000-02-17       Impact factor: 91.245

Review 7.  Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice.

Authors:  S Ishii; T Shimizu
Journal:  Prog Lipid Res       Date:  2000-01       Impact factor: 16.195

8.  Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide.

Authors:  M Zayek; D Cleveland; F C Morin
Journal:  J Pediatr       Date:  1993-05       Impact factor: 4.406

9.  Effect of long-term high-altitude hypoxia on fetal pulmonary vascular contractility.

Authors:  Qin Xue; Charles A Ducsay; Lawrence D Longo; Lubo Zhang
Journal:  J Appl Physiol (1985)       Date:  2008-04-03

10.  Maternal high-altitude hypoxia and suppression of ryanodine receptor-mediated Ca2+ sparks in fetal sheep pulmonary arterial myocytes.

Authors:  Scott R Hadley; Quintin Blood; Monica Rubalcava; Edith Waskel; Britney Lumbard; Petersen Le; Lawrence D Longo; John N Buchholz; Sean M Wilson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-09-07       Impact factor: 5.464

View more
  8 in total

1.  Developmental programming: Interaction between prenatal BPA and postnatal overfeeding on cardiac tissue gene expression in female sheep.

Authors:  L A Koneva; A K Vyas; R C McEachin; M Puttabyatappa; H-S Wang; M A Sartor; V Padmanabhan
Journal:  Environ Mol Mutagen       Date:  2017-01-12       Impact factor: 3.216

Review 2.  Neonatal oxygenation, pulmonary hypertension, and evolutionary adaptation to high altitude (2013 Grover Conference series).

Authors:  Susan Niermeyer; Mario Patricio Andrade-M; Enrique Vargas; Lorna G Moore
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

3.  Decreased endothelial nitric oxide synthase expression and function contribute to impaired mitochondrial biogenesis and oxidative stress in fetal lambs with persistent pulmonary hypertension.

Authors:  Adeleye J Afolayan; Annie Eis; Maxwell Alexander; Teresa Michalkiewicz; Ru-Jeng Teng; Satyan Lakshminrusimha; Girija G Konduri
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-10-30       Impact factor: 5.464

4.  Long-term high-altitude hypoxia influences pulmonary arterial L-type calcium channel-mediated Ca2+ signals and contraction in fetal and adult sheep.

Authors:  Christine P Shen; Monica Romero; Alexander Brunelle; Craig Wolfe; Abigail Dobyns; Michael Francis; Mark S Taylor; Jose L Puglisi; Lawrence D Longo; Lubo Zhang; Christopher G Wilson; Sean M Wilson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-11-22       Impact factor: 3.619

5.  Efficacy of Bosentan in patients after Fontan procedures: a double-blind, randomized controlled trial.

Authors:  Xiao-Ke Shang; Rong Lu; Xi Zhang; Chang-Dong Zhang; Shu-Na Xiao; Mei Liu; Bin Wang; Nian-Guo Dong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-28

6.  Persistent pulmonary hypertension alters the epigenetic characteristics of endothelial nitric oxide synthase gene in pulmonary artery endothelial cells in a fetal lamb model.

Authors:  Xingrao Ke; Hollis Johnson; Xigang Jing; Teresa Michalkiewicz; Yi-Wen Huang; Robert H Lane; Girija G Konduri
Journal:  Physiol Genomics       Date:  2018-07-13       Impact factor: 3.107

Review 7.  Gestational Hypoxia and Developmental Plasticity.

Authors:  Charles A Ducsay; Ravi Goyal; William J Pearce; Sean Wilson; Xiang-Qun Hu; Lubo Zhang
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

8.  Long term hypoxia during gestation alters perirenal adipose tissue gene expression in the lamb.

Authors:  Dean A Myers; Krista Singleton; Kim Hyatt; Kanchan M Kaushal; Charles A Ducsay
Journal:  Adipocyte       Date:  2020-12       Impact factor: 4.534

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.